Abnormal skeletal muscle bioenergetics in familial hypertrophic cardiomyopathy

Heart

Volumn 78, Issue 2, 1997, Pages 177-181

  Thompson, Campbell H ^a   Kemp, Graham J ^a,c   Taylor, Doris J ^a   Conway, Michael ^a   Rajagopalan, Bheeshma ^a   O'Donoghue, Annie ^b   Styles, Peter ^a   McKenna, William J ^b   Radda, George K ^a  

^a JOHN RADCLIFFE HOSPITAL   (United Kingdom)

^b ST GEORGE S HOSPITAL   (United Kingdom)

^c ROYAL LIVERPOOL UNIVERSITY HOSPITAL   (United Kingdom)

Author keywords

Hypertrophic cardiomyopathy; Magnetic resonance spectroscopy; Metabolism; Skeletal muscle

Indexed keywords

ADENOSINE TRIPHOSPHATE; AMIODARONE; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CREATINE PHOSPHATE; DILTIAZEM; MYOSIN HEAVY CHAIN; TROPONIN T; VERAPAMIL;

AEROBIC METABOLISM; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; EXERCISE; HEART MUSCLE; HISTOPATHOLOGY; HUMAN; HUMAN CELL; HUMAN TISSUE; HYPERTROPHIC CARDIOMYOPATHY; MUSCLE TWITCH; PHOSPHATE METABOLISM; PHOSPHORUS NUCLEAR MAGNETIC RESONANCE; PRIORITY JOURNAL; SKELETAL MUSCLE;

EID: 0030833361     PISSN: 13556037     EISSN: None     Source Type: Journal    
DOI: 10.1136/hrt.78.2.177     Document Type: Article

References (18)

1. Maron B, Bonow R, Cannon R, Leon M, Epstein S. Hypertrophic cardiomyopathy: interrelations of clinical manifestations, pathophysiology, and therapy. N Engl J Med 1987;316:780-9, 844-52.
2. Watkins H, Rosenzweig A, Hwang D-S, Levi T, McKenna W, Seidmann CE, et al. Characteristics and prognostic implications of myosin missense mutations in familial hypertrophic cardiomyopathy. N Engl J Med 1992;326:1108-14.
3. Watkins H, McKenna W, Thierfelder L, Suk HJ, Anan R, O'Donoghue A, et al. Mutations in the genes for cardiac troponin T and α tropomyosin in hypertrophic cardiomy- opathy. N Engl J Med 1995;332:1058-64.
4. Sutton M, Lie J, Anderson K, O'Brien P, Frye R. Histopathological specificity of hypertrophic obstructive cardiomyopathy. Br Heart J 1980;44:433-43.
5. Anan R, Greve G, Thierfelder L, Watkins H, McKenna WJ, Solomon S, et al. Prognostic implications of novel β cardiac myosin heavy chain mutations that cause familial hypertrophic cardiomyopathy. J Clin Invest 1994;93:280-5.
6. Cuda G, Fananapazir L, Zhu W-S, Sellers J, Epstein N. Skeletal muscle expression and abnormal function of myosin in hypertrophic cardiomyopathy. J Clin Invest 1993;91:2861-5.
7. Lankford E, Epstein N, Fananapazir L, Sweeney H. Abnormal contractile properties of muscle fibers expressing β-myosin heavy chain gene mutations in patients with hypertrophic cardiomyopathy. J Clin Invest 1995;95:1409-14.
8. Anderson P, Malouf N, Oakeley A, Pagani E, Allen P. Troponin T isoform expression in humans. Circ Res 1991;69:1226-33.
9. Durnin J, Womersley J. Body fat assessed from total body density and its estimation from skinfold thickness; measurements in 481 men and women aged from 16 to 72 years. Br J Nutr 1974;32:77-97.
10. Arnold DL, Matthews PM, Radda GK. Metabolic recovery after exercise and the assessment of mitochondrial function in vivo in human skeletal muscle by means of P-31 NMR. Magn Reson Med 1984;1:307-15.
11. Kemp GJ, Thompson CH, Taylor DJ, Hands LJ, Rajagopalan B, Radda GK. Quantitative analysis by "P MRS of abnormal mitochondrial oxidation in skeletal muscle during recovery from exercise. NMR Biomed 1993;6:302-10.
12. Meyer R, Brown T, Kushmerick M. Phosphorus nuclear magnetic resonance of fast- and slow-twitch muscle. Am J Physiol 1985;248:C279-87.
13. Vandenborne K, Walter G, Ploutz-Snyder L, Staron R, Fry A, de Meirleir K, et al. Energy-rich phosphates in slow and fast human skeletal muscle. Am J Physiol 1995;268:C869-76.
14. Fananapazir L, Dalakas M, Cyran F, Cohn G, Epstein N. Missense mutations in the β myosin heavy-chain gene cause central core disease in hypertrophic myopathy. Proc Natl Acad Sci USA 1993;90:3993-7.
15. Smith ER, Heffernan LP, Sangalang VE, Vaughan LM, Flemington CS. Voluntary muscle involvement in hypertrophic cardiomyopathy. Ann Intern Med 1976;85:566-72.
16. Ryschon T, Fowler M, Arai A, Wysong RE, McAreavey D, Epstein ND, et al. Muscle energetics during dynamic exercise in hypertrophic cardiomyopathy [abstract]. Circulation 1994;90:I-442.
17. Barnes P, Taylor D, Kemp G, Radda G. Skeletal muscle bioenergetics in the chronic fatigue syndrome. J Neurol Neurosurg Psychiatry 1993;56:679-83.
18. Spirito P, Maron BJ, Bonow RO, Epstein SE. Severe functional limitation in patients with hypertrophic cardiomyopathy and only mild localized left ventricular hypertrophy. J Am Coll Cardiol 1986;8:537-44.